Kumaraguru Raja
Stock Analyst at Brookline Capital Markets
(0.24)
# 4,516
Out of 4,696 analysts
206
Total ratings
31.4%
Success rate
-5.5%
Average return
Main Sectors:
Stocks Rated by Kumaraguru Raja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences | Downgraded: Hold | $54 → $77 | $76.99 | +0.01% | 7 | Jul 27, 2026 | |
| EDSA Edesa Biotech | Initiated Coverage: Buy | $18 → $21 | $4.62 | +354.55% | 10 | Jun 29, 2026 | |
| ERNA Ernexa Therapeutics | Initiated Coverage: Buy | $30 | $4.57 | +556.46% | 1 | May 7, 2026 | |
| IRD Opus Genetics | Initiated Coverage: Buy | $10 → $8 | $3.69 | +116.80% | 4 | Dec 1, 2025 | |
| MDCX Medicus Pharma | Maintained: Buy | $12 → $20 | $0.2577 | +7,660.96% | 2 | Sep 24, 2025 | |
| NBP NovaBridge Biosciences | Maintained: Buy | $6 → $8 | $1.84 | n/a | 2 | Aug 28, 2025 | |
| INTS Intensity Therapeutics | Upgraded: Buy | $75 | $4.25 | n/a | 2 | Aug 12, 2025 | |
| ADIL Adial Pharmaceuticals | Maintained: Buy | $8 → $50 | $5.60 | n/a | 4 | Jun 26, 2025 | |
| HURA TuHURA Biosciences | Initiated Coverage: Buy | $9 | $2.11 | n/a | 1 | Jun 23, 2025 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $3 → $58 | $111.89 | n/a | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $33.75 | n/a | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $2.00 | n/a | 1 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $1.64 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $5.27 | n/a | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.79 | n/a | 1 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.00 | n/a | 1 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.2 | $0.985 | n/a | 3 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.54 | n/a | 1 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 → $5 | $0.735 | n/a | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $74 | $0.0001 | n/a | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $330 | $0.0001 | n/a | 3 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.39 | n/a | 9 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $2.63 | n/a | 20 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.6449 | n/a | 9 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $15.19 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $7 | $0.50165 | n/a | 8 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.15 | n/a | 6 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.19 | n/a | 6 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.69 | n/a | 5 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.86 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.00 | $0.48 | n/a | 5 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $1.60 | n/a | 8 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $2 | $1.34 | n/a | 2 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.37 | n/a | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.095 | n/a | 5 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $5.52 | n/a | 1 | Feb 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $0.001 | n/a | 9 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.53 | n/a | 3 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.83 | n/a | 2 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.32 | n/a | 3 | Dec 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $10.91 | n/a | 4 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.59 | n/a | 1 | Aug 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.22 | n/a | 2 | Aug 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.82 | n/a | 1 | May 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.99 | n/a | 2 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $2.27 | n/a | 1 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.3266 | n/a | 1 | May 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $0.4 | $13.21 | n/a | 2 | Jun 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $537 → $480 | $794.19 | n/a | 4 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $145.68 | n/a | 1 | Apr 6, 2015 |
Forte Biosciences
Jul 27, 2026
Downgraded: Hold
Price Target: $54 → $77
Current: $76.99
Upside: +0.01%
Edesa Biotech
Jun 29, 2026
Initiated Coverage: Buy
Price Target: $18 → $21
Current: $4.62
Upside: +354.55%
Ernexa Therapeutics
May 7, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $4.57
Upside: +556.46%
Opus Genetics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $10 → $8
Current: $3.69
Upside: +116.80%
Medicus Pharma
Sep 24, 2025
Maintained: Buy
Price Target: $12 → $20
Current: $0.2577
Upside: +7,660.96%
NovaBridge Biosciences
Aug 28, 2025
Maintained: Buy
Price Target: $6 → $8
Current: $1.84
Upside: n/a
Intensity Therapeutics
Aug 12, 2025
Upgraded: Buy
Price Target: $75
Current: $4.25
Upside: n/a
Adial Pharmaceuticals
Jun 26, 2025
Maintained: Buy
Price Target: $8 → $50
Current: $5.60
Upside: n/a
TuHURA Biosciences
Jun 23, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $2.11
Upside: n/a
Monopar Therapeutics
May 13, 2025
Maintained: Buy
Price Target: $3 → $58
Current: $111.89
Upside: n/a
Dec 18, 2024
Initiated Coverage: Buy
Price Target: $9
Current: $33.75
Upside: n/a
Nov 20, 2024
Initiated Coverage: Buy
Price Target: $38
Current: $2.00
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $9
Current: $1.64
Upside: n/a
Jul 9, 2024
Initiated Coverage: Buy
Price Target: $80
Current: $5.27
Upside: n/a
Jun 6, 2024
Initiated Coverage: Buy
Price Target: $8
Current: $3.79
Upside: n/a
Jun 29, 2023
Initiated Coverage: Buy
Price Target: $15
Current: $1.00
Upside: n/a
May 30, 2023
Downgraded: Hold
Price Target: $2 → $1.2
Current: $0.985
Upside: n/a
Mar 3, 2023
Initiated Coverage: Buy
Price Target: $9
Current: $0.54
Upside: n/a
Jan 5, 2023
Initiated Coverage: Buy
Price Target: $6 → $5
Current: $0.735
Upside: n/a
Nov 29, 2022
Maintained: Buy
Price Target: $80 → $74
Current: $0.0001
Upside: n/a
Oct 17, 2022
Maintained: Buy
Price Target: $12 → $330
Current: $0.0001
Upside: n/a
Aug 15, 2022
Maintained: Buy
Price Target: n/a
Current: $5.39
Upside: n/a
Aug 11, 2022
Maintained: Buy
Price Target: $31
Current: $2.63
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $6
Current: $0.6449
Upside: n/a
Aug 10, 2022
Reiterated: Buy
Price Target: $74
Current: $15.19
Upside: n/a
Aug 8, 2022
Rated: Buy
Price Target: $10 → $7
Current: $0.50165
Upside: n/a
Aug 1, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.15
Upside: n/a
Jun 2, 2022
Reiterated: Buy
Price Target: $12
Current: $3.19
Upside: n/a
May 24, 2022
Maintained: Buy
Price Target: n/a
Current: $1.69
Upside: n/a
May 13, 2022
Reiterated: Buy
Price Target: $22
Current: $0.86
Upside: n/a
May 2, 2022
Reiterated: Buy
Price Target: $14.00
Current: $0.48
Upside: n/a
Apr 5, 2022
Reiterated: Buy
Price Target: $45
Current: $1.60
Upside: n/a
Sep 28, 2021
Maintained: Buy
Price Target: $14 → $2
Current: $1.34
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $7
Current: $5.37
Upside: n/a
Mar 23, 2021
Reiterated: Buy
Price Target: $12 → $6
Current: $0.095
Upside: n/a
Feb 2, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $5.52
Upside: n/a
Dec 16, 2020
Reiterated: Buy
Price Target: $35
Current: $0.001
Upside: n/a
Feb 20, 2020
Reiterated: Buy
Price Target: $6
Current: $2.53
Upside: n/a
Mar 28, 2019
Rated: Hold
Price Target: n/a
Current: $3.83
Upside: n/a
Dec 24, 2018
Rated: Hold
Price Target: n/a
Current: $1.32
Upside: n/a
Oct 22, 2018
Maintained: Buy
Price Target: $25
Current: $10.91
Upside: n/a
Aug 30, 2018
Maintained: Hold
Price Target: n/a
Current: $13.59
Upside: n/a
Aug 4, 2017
Reiterated: Buy
Price Target: n/a
Current: $2.22
Upside: n/a
May 26, 2017
Reiterated: Buy
Price Target: n/a
Current: $9.82
Upside: n/a
May 22, 2017
Reiterated: Buy
Price Target: n/a
Current: $2.99
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $10
Current: $2.27
Upside: n/a
May 10, 2017
Reiterated: Buy
Price Target: n/a
Current: $0.3266
Upside: n/a
Jun 29, 2016
Downgraded: Hold
Price Target: $3.5 → $0.4
Current: $13.21
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $537 → $480
Current: $794.19
Upside: n/a
Apr 6, 2015
Reiterated: Buy
Price Target: $120
Current: $145.68
Upside: n/a